Asset Publisher

Institutional

ISGlobal and Made of Genes Join Forces to Revolutionise Sports Health through Artificial Intelligence

The partnership brings together ISGlobal’s research excellence and Made of Genes’ technological leadership, strengthening the innovation ecosystem alongside the Barça Innovation Hub

04.02.2026

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, and Made of Genes, a Genomcore spin-off, have announced a strategic agreement to transform injury prevention during physical activity.

The transaction has been carried out through a “license for equity” arrangement, a technology-transfer model in which ISGlobal licenses advanced injury-prevention software in exchange for shares in the start-up.

Science and technology in the service of performance

This collaboration combines ISGlobal’s scientific expertise with Made of Genes’ artificial intelligence platform to improve sports performance and multimodal data management, maximising the efficiency of personalised medicine. The transferred knowledge and algorithm, developed by the team led by Dr Juan Ramón González, use predictive models to analyse “sportomics” data (the integration of sport with genomics and metabolomics) and physical activity load. The alliance between ISGlobal and Made of Genes builds on the collaboration both institutions maintain with the Barça Innovation Hub to develop models that integrate omics data and physical load.

ISGlobal and Made of Genes have also signed a framework collaboration agreement to explore new frontiers in precision medicine and global health, leveraging the synergies between ISGlobal’s research teams and Genomcore’s technological execution capabilities.

Thanks to this alliance, Made of Genes consolidates its leadership in the sector, while ISGlobal strengthens its role as a key player in the health innovation ecosystem through spin-offs and technology transfer, contributing scientific rigour to optimise health through physical activity. This partnership enables precision medicine to move from research into real-world application, improving active prevention and longevity.